We further analyzed the 12-month OS in HCC patients with AFP <400 ng/ml or AFP ≥400 ng/ml, tumor number <3 or tumor number ≥3, and tumor diameter <5 cm or tumor diameter ≥5 cm who underwent TACE + RFA or TACE alone. Here, AFP is linked to hepatocellular carcinoma.